Dupont Capital Management Corp Precigen, Inc. Transaction History

Dupont Capital Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 28, 2021	SELL	$3.75 - $10.56 $222,150 - $625,574	-59,240 Closed	0 $0
Q3 2020 Oct 29, 2020	SELL	$3.5 - $6.2 $13,888 - $24,601	-3,968 Reduced 6.28%	59,240 $207,000
Q2 2020 Jul 24, 2020	SELL	$2.16 - $5.46 $12,188 - $30,810	-5,643 Reduced 8.2%	63,208 $315,000
Q1 2020 Apr 29, 2020	BUY	$1.46 - $7.19 $100,522 - $495,038	68,851 New	68,851 $234,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $246M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.